Esaote claims Ultrasound breakthrough:
This article was originally published in Clinica
Esaote launched an ultra-high performance ultrasound device at the Radiological Society of North America meeting in Chicago last month. The Technos claims to incorporate a research breakthrough in probe technology from the Genova, Italy-based company. The Technos can visualise subtle vascular morphology and very slow blood flows, enabling high visibility of vascular detail, including the intimal lining of the carotid artery and minute leg vessels.
You may also be interested in...
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Bangladesh’s Beximco will market Mylan’s biosimilars in its domestic market, under a deal that has just been struck between the two companies. The Ogivri trastuzumab biosimilar, co-developed by Mylan and Biocon, will be the first product launched as part of the collaboration.